Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Testing NTRK testing: Wet‐lab and in silico comparison of RNA‐based targeted sequencing assays

25 Oct 2019

Abstract excerpt

NTRK fusions involving three neurotrophic tyrosine receptor kinase genes NTRK1, NTRK2, and NTRK3 and a variety of fusion partners were identified as oncogenic drivers across many cancer types. Drugs that target the chimeric protein product require the identification of the underlying gene fusion. This advocates the diagnostic use of molecular assays ranging from fluorescence in situ hybridization (FISH) and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Lung Cancer Treatments and Mutations
Share to RNA Research and Splicing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31652375
DOI: 10.1002/gcc.22819

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Testing NTRK testing: Wet‐lab and in silico comparison of RNA‐based targeted sequencing assaysPMID 31652375Read ↗

Evaluating Targeted Next-Generation Sequencing Assays and Reference Materials for NTRK Fusion DetectionSemantic proximity Read ↗

Consensus Recommendations to Optimize the Detection and Reporting of NTRK Gene Fusions by RNA-Based Next-Generation SequencingSemantic proximity Read ↗

NTRK gene fusion testing and management in lung cancerSemantic proximity Read ↗

NTRK Fusions, from the Diagnostic Algorithm to Innovative Treatment in the Era of Precision MedicineSemantic proximity Read ↗

Detection of NTRK Fusions: Merits and Limitations of Current Diagnostic PlatformsSemantic proximity Read ↗

Testing algorithm for identification of patients with TRK fusion cancerSemantic proximity Read ↗

Cost-Efficient Detection of NTRK1/2/3 Gene Fusions: Single-Center Analysis of 8075 Tumor SamplesSemantic proximity Read ↗

Pan-TRK Immunohistochemistry: An Example-Based Practical Approach to Efficiently Identify Patients With NTRK Fusion Cancer.Semantic proximity Read ↗

Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in AdultsSemantic proximity Read ↗

Detecting Gene Rearrangements in Patient Populations Through a 2-Step Diagnostic Test Comprised of Rapid IHC Enrichment Followed by Sensitive Next-Generation SequencingSemantic proximity Read ↗

NTRK Gene Fusions in Non-Small-Cell Lung Cancer: Real-World Screening Data of 1068 Unselected PatientsSemantic proximity Read ↗

Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world populationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.